Matthew Choy

15PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical bacteriologyCancer diagnosisInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 18, 2026
Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series.

|Apr 24, 2026
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis.

|Mar 02, 2026
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department.

Christopher F D Li Wai Suen, Shipraa Kaul, Ethan X Z Tan

|Jul 15, 2025
Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation.

Simone Chin, Danny Con, Patrick Hilley

|Sep 19, 2023
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis.

Christopher F D Li Wai Suen, Dean Seah, Matthew C Choy

|May 12, 2023
DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making.

Misha Kabir, Siwan Thomas-Gibson, Phil J Tozer

Pageof 3

Frequent Collaborators

8 joint publications

Peter De Cruz

5 joint publications

Christopher F D Li Wai Suen

2 joint publications

Daniel Van Langenberg

2 joint publications

Siwan Thomas-Gibson